DEA Sets New Import, Export Restrictions for Methiopropamine

The Drug Enforcement Administration is listing methiopropamine, a central nervous stimulant that is structurally related to the schedule II stimulants methamphetamine and amphetamine, under schedule I of the Controlled Substances Act, it said in a notice released Dec. 8. “This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle methiopropamine," DEA said. The listing takes effect Jan. 9.